Literature DB >> 17710223

Proof-of-Principle to Measure Potassium in the Human Brain: A Feasibility Study.

L Wielopolski1, L M Ramirez, P K Coyle, Z M Wang, S B Heymsfield.   

Abstract

We describe the results of a proof-of-principle to measure the potassium content in the human brain using the natural radioisotope (40)K that is in equilibrium with the stable isotopes of potassium, (39)K and (41)K. A fixed relationship exists between radioactive potassium and the total potassium in the brain, which in turn reflects the brain's cell mass and intracellular water compartment. Accordingly, we explored whether measurements of brain potassium could serve as possible indicators of intracellular cerebral edema. We designed, built, and then calibrated our system using a spherical phantom containing KCl salt dissolved in water at levels comparable to those in the human brain. Emitted radiation was detected using sodium iodide (Nal) and high-purity germanium (HP-Ge) detectors. Our results with phantoms and with five volunteers demonstrate the feasibility of measuring potassium at the levels normally present in human brain tissue. We plan to extend the system to detect the onset of brain edema in patients with multiple sclerosis.

Entities:  

Year:  2004        PMID: 17710223      PMCID: PMC1950144     

Source DB:  PubMed          Journal:  Int J Body Compos Res        ISSN: 1479-456X


  12 in total

1.  PROBLEMS INVOLVED IN ACCURATELY MEASURING THE K CONTENT OF THE HUMAN BODY.

Authors:  C E MILLER; A P REMENCHIK
Journal:  Ann N Y Acad Sci       Date:  1963-09-26       Impact factor: 5.691

2.  Body sodium and potassium. III. Interrelated trends in alimentary, renal and cardiovascular disease; lack of correlation between body stores and plasma concentration.

Authors:  F D MOORE; I S EDELMAN; J M OLNEY; A H JAMES; L BROOKS; G M WILSON
Journal:  Metabolism       Date:  1954-07       Impact factor: 8.694

3.  A serial study of new MS lesions and the white matter from which they arise.

Authors:  D E Goodkin; W D Rooney; R Sloan; P Bacchetti; L Gee; M Vermathen; E Waubant; M Abundo; S Majumdar; S Nelson; M W Weiner
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  The 40K activity of one gram of potassium.

Authors:  S B Samat; S Green; A H Beddoe
Journal:  Phys Med Biol       Date:  1997-02       Impact factor: 3.609

5.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  Absolute measurement of whole-body potassium by gamma-ray spectrometry.

Authors:  S H Cohn; C S Dombrowski
Journal:  J Nucl Med       Date:  1970-06       Impact factor: 10.057

7.  Some spaces and barriers in postmortem multiple sclerosis.

Authors:  W W Tourtellotte; J A Parker
Journal:  Prog Brain Res       Date:  1968       Impact factor: 2.453

8.  Application of the library least-squares analysis to whole-body counter spectra derived from an array of detectors.

Authors:  L Wielopolski; S H Cohn
Journal:  Med Phys       Date:  1984 Jul-Aug       Impact factor: 4.071

9.  Body cell mass: model development and validation at the cellular level of body composition.

Authors:  ZiMian Wang; Marie-Pierre St-Onge; Beatriz Lecumberri; F Xavier Pi-Sunyer; Stanley Heshka; Jack Wang; Donald P Kotler; Dympna Gallagher; Lucian Wielopolski; Richard N Pierson; Steven B Heymsfield
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-10-07       Impact factor: 4.310

10.  Some aspects of measuring levels of potassium in the brain.

Authors:  L Wielopolski; L M Ramirez; P Coyle; S Heymsfield; J Zimman
Journal:  Acta Diabetol       Date:  2003-10       Impact factor: 4.280

View more
  1 in total

1.  Measuring partial body potassium in the arm versus total body potassium.

Authors:  L Wielopolski; L M Ramirez; D Gallagher; S R Sarkar; F Zhu; G A Kaysen; N W Levin; S B Heymsfield; Z M Wang
Journal:  J Appl Physiol (1985)       Date:  2006-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.